24 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Protacs targeting coronavirus 3CL protease and preparation method and application thereof
Shaanxi Panlong Pharmaceutical
Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists
Bristol-Myers Squibb
Development of Selective Inhibitors for Human Aldehyde Dehydrogenase 3A1 (ALDH3A1) for the Enhancement of Cyclophosphamide Cytotoxicity.
Indiana University
Long residence times revealed by Aurora A kinase-targeting fluorescent probes derived from inhibitors MLN8237 and VX-689.
University of Tartu
Compositions for preventing and/or treating degenerative disorders of the central nervous system
Amicus Therapeutics
Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
Selvita
Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
Sanofi
Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
Inotek Pharmaceuticals
Methods and compositions for sleep disorders and other disorders
Intra-Cellular Therapies
Development of fragment-based n-FABS NMR screening applied to the membrane enzyme FAAH.
Fondazione Istituto Italiano Di Tecnologia
DXP synthase-catalyzed C-N bond formation: nitroso substrate specificity studies guide selective inhibitor design.
The Johns Hopkins University
New insights into the pharmacological chaperone activity of c2-substituted glucoimidazoles for the treatment of Gaucher disease.
Nankai University